Potential participants must meet all of the following: <br/ >1. Laboratory-confirmed diagnosis of SARS-CoV-2 infection <br/ >a. Confirmation through appropriate approved laboratory or Point of Care testing method, <br/ >including Polymerase Chain Reaction or other public health assay. <br/ >2. Age greater than or equal to 18 years <br/ >3. Either <br/ >a. Systolic BP (SBP) greater than or equal to 125mmHg <br/ >OR <br/ >b. SBP greater than or equal to 115mmHg and currently treated with a non-RAS inhibitor (RASi) BP-lowering agent <br/ >that can be ceased <br/ >4. Participant and treating staff are willing and able to perform trial procedures. <br/ >5. Intended for admission to a participating hospital for management of COVID-19 <br/ >6. Diagnosis (i.e. date of test result) for SARS-CoV-2 infection must be within 3 days prior to <br/ >randomisation <br/ >

Potential participants must meet all of the following: <br/ >1. Laboratory-confirmed diagnosis of SARS-CoV-2 infection <br/ >a. Confirmation through appropriate approved laboratory or Point of Care testing method, <br/ >including Polymerase Chain Reaction or other public health assay. <br/ >2. Age greater than or equal to 18 years <br/ >3. Either <br/ >a. Systolic BP (SBP) greater than or equal to 125mmHg <br/ >OR <br/ >b. SBP greater than or equal to 115mmHg and currently treated with a non-RAS inhibitor (RASi) BP-lowering agent <br/ >that can be ceased <br/ >4. Participant and treating staff are willing and able to perform trial procedures. <br/ >5. Intended for admission to a participating hospital for management of COVID-19 <br/ >6. Diagnosis (i.e. date of test result) for SARS-CoV-2 infection must be within 3 days prior to <br/ >randomisation <br/ >

Potential participants must meet all of the following: <br/ >1. Laboratory-confirmed diagnosis of SARS-CoV-2 infection <br/ >a. Confirmation through appropriate approved laboratory or Point of Care testing method, <br/ >including Polymerase Chain Reaction or other public health assay. <br/ >2. Age greater than or equal to 18 years <br/ >3. Either <br/ >a. Systolic BP (SBP) greater than or equal to 125mmHg <br/ >OR <br/ >b. SBP greater than or equal to 115mmHg and currently treated with a non-RAS inhibitor (RASi) BP-lowering agent <br/ >that can be ceased <br/ >4. Participant and treating staff are willing and able to perform trial procedures. <br/ >5. Intended for admission to a participating hospital for management of COVID-19 <br/ >6. Diagnosis (i.e. date of test result) for SARS-CoV-2 infection must be within 3 days prior to <br/ >randomisation <br/ >

Potential participants must meet all of the following: <br/ >1. Laboratory-confirmed diagnosis of SARS-CoV-2 infection <br/ >a. Confirmation through appropriate approved laboratory or Point of Care testing method, <br/ >including Polymerase Chain Reaction or other public health assay. <br/ >2. Age greater than or equal to 18 years <br/ >3. Either <br/ >a. Systolic BP (SBP) greater than or equal to 125mmHg <br/ >OR <br/ >b. SBP greater than or equal to 115mmHg and currently treated with a non-RAS inhibitor (RASi) BP-lowering agent <br/ >that can be ceased <br/ >4. Participant and treating staff are willing and able to perform trial procedures. <br/ >5. Intended for admission to a participating hospital for management of COVID-19 <br/ >6. Diagnosis (i.e. date of test result) for SARS-CoV-2 infection must be within 3 days prior to <br/ >randomisation <br/ >